What is the Coscens Biopharma Inc. stock price forecast?

Coscens Biopharma Inc. is currently trading at $1.87. View real-time AI analysis on Alpha Lenz.

What is Coscens Biopharma Inc. insider trading activity?

View the latest insider trading data for Coscens Biopharma Inc. on Alpha Lenz.

What is Coscens Biopharma Inc.'s P/E ratio?

Coscens Biopharma Inc.'s P/E ratio is -0.3.

Coscens Biopharma Inc.

NASDAQ · CSCI

$1.87+0.11(+6.25%)Pre-market

Ask about Coscens Biopharma Inc.'s future dividend policy...

Alpha Chat Insight

“Coscens Biopharma Inc. trades at a P/E of -0.3 (undervalued) with modest ROE of -89.6%.”

Ask for details →

Company Overview

Coscens Biopharma Inc. is a biotechnology company focused on the development and commercialization of novel therapeutic solutions in the healthcare sector. Specializing in the research and advancement of drugs that address unmet medical needs, Coscens Biopharma targets a range of serious health conditions with an emphasis on rare diseases and breakthrough therapies. The company leverages cutting-edge technology and innovative approaches in molecular biology to create its product pipeline, aiming to improve patient outcomes and provide new treatment options. Operating within the dynamic biopharmaceutical industry, Coscens Biopharma plays a crucial role in advancing medical research and contributing to the biotechnological landscape. The company's endeavors are instrumental in shaping the future of healthcare, fostering collaborations with research institutions and strategic partnerships to expedite the discovery and delivery of transformative medicines. With a focus on rigorous scientific research and development, Coscens Biopharma Inc. is positioned as a key player in facilitating advancements that meet critical healthcare challenges today.

CEOMr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.

Websitehttps://www.cosciensbio.com

SectorHealthcare

IndustryBiotechnology

Employees40

Company Statistics

FY 2024

Profile

$4.83MMarket Cap

$9.59MRevenue

0.00Shares Out

40Employees

Margins

49.33%Gross

-123.89%EBITDA

-146.27%Operating

-158.81%Pre-Tax

-159.69%Net

Valuation

-0.32P/E

0.37P/B

0.50EV/Sales

0.78EV/EBITDA

-0.31P/FCF

Growth (CAGR)

-10.75%Rev 3Yr

-0.56%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-52.09%ROA

-89.64%ROE

-51.37%ROIC

Financial Health

$16.39MCash & Cash Equivalents

$5.52MNet Debt

166.47%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Coscens Biopharma Inc. trades at a P/E of -0.3 (undervalued) with modest ROE of -89.6%.”

Ask for details →

Frequently Asked Questions

Coscens Biopharma Inc. (ticker: CSCI) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 40 employees. Market cap is $5M.

The current price is $1.87 with a P/E ratio of -0.32x and P/B of 0.37x.

ROE is -89.64% and operating margin is -146.27%. Annual revenue is $10M.